Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Iradimed Cp (IRMD)

Iradimed Cp (IRMD)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Iradimed Corp Has Returned 10.7% Since SmarTrend Recommendation (IRMD)

SmarTrend identified an Uptrend for Iradimed Corp (NASDAQ:IRMD) on March 31st, 2020 at $20.41. In approximately 5 months, Iradimed Corp has returned 10.73% as of today's recent price of $22.60.

IRMD : 22.36 (-0.58%)
6.8% Return Seen to Date on SmarTrend Iradimed Corp Call (IRMD)

SmarTrend identified an Uptrend for Iradimed Corp (NASDAQ:IRMD) on March 31st, 2020 at $20.41. In approximately 4 months, Iradimed Corp has returned 6.76% as of today's recent price of $21.79.

IRMD : 22.36 (-0.58%)
18.9% Return Seen to Date on SmarTrend Iradimed Corp Call (IRMD)

SmarTrend identified an Uptrend for Iradimed Corp (NASDAQ:IRMD) on March 31st, 2020 at $20.41. In approximately 2 months, Iradimed Corp has returned 18.86% as of today's recent price of $24.26.

IRMD : 22.36 (-0.58%)
IRADIMED CORPORATION Names Roger Susi as President and Chief Executive Officer

IRADIMED CORPORATION (NASDAQ: IRMD), announced today that its Board of Directors has appointed Roger Susi to resume his duties as the Company's President and Chief Executive Officer after the departure...

IRMD : 22.36 (-0.58%)
IRADIMED CORPORATION Announces Issuance of U.S. Patent

IRADIMED CORPORATION (NASDAQ:IRMD), today announced the issuance by the U.S. Patent and Trademark Office of a patent that expands on previous claims pertaining to the wireless remote control of IV infusion...

IRMD : 22.36 (-0.58%)
IRadimed (IRMD) Q1 Earnings Surpass Estimates

iRadimed (IRMD) delivered earnings and revenue surprises of 50.00% and -0.48%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

IRMD : 22.36 (-0.58%)
IRADIMED CORPORATION Announces First Quarter 2020 Financial Results

-- Reports first quarter 2020 revenue of $8.7 million, GAAP diluted EPS of $0.14 and non-GAAP diluted EPS of $0.18

IRMD : 22.36 (-0.58%)
IRADIMED CORPORATION to Hold 2020 First Quarter Financial Results Conference Call on April 30th

IRMD : 22.36 (-0.58%)
IRADIMED CORPORATION Withdraws 2020 Financial Guidance Due to Uncertainties from the Effects of COVID-19

IRADIMED CORPORATION (NASDAQ: IRMD) announced that it expects to report first quarter 2020 revenue of $8.6 million to $8.7 million and is withdrawing its first quarter and full year 2020 financial guidance...

IRMD : 22.36 (-0.58%)
IRADIMED CORPORATION Announces the Appointment of Lynn Neuhardt as Vice President of Research and Development

IRADIMED CORPORATION (NASDAQ: IRMD) announced the appointment of Lynn Neuhardt as Vice President of Research and Development, effective March 26, 2020. Mr. Neuhardt will report to Leslie McDonnell, President...

IRMD : 22.36 (-0.58%)
IRADIMED CORPORATION to Present at the 32nd Annual Roth Conference

IRADIMED CORPORATION (NASDAQ: IRMD) today announced that Leslie McDonnell, President and Chief Executive Officer, will present at the 32 Annual Roth Conference in Laguna Niguel, CA. Ms. McDonnell is scheduled...

IRMD : 22.36 (-0.58%)
IRADIMED CORPORATION Announces Retirement of Francis Casey and the Appointment of Steven Kachelmeyer as Vice President of Regulatory Affairs and Quality Assurance

IRADIMED CORPORATION (NASDAQ: IRMD) announced the retirement of Francis Casey, Vice President of Regulatory Affairs and Quality Assurance, effective June 30, 2020 after leading the Company's regulatory...

IRMD : 22.36 (-0.58%)
Uptrend Call Working As Iradimed Corp Stock Rises 15.5% (IRMD)

SmarTrend identified an Uptrend for Iradimed Corp (NASDAQ:IRMD) on July 30th, 2019 at $22.77. In approximately 7 months, Iradimed Corp has returned 15.48% as of today's recent price of $26.29.

IRMD : 22.36 (-0.58%)
IRadimed (IRMD) Tops Q4 Earnings Estimates

iRadimed (IRMD) delivered earnings and revenue surprises of 50.00% and -0.63%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

IRMD : 22.36 (-0.58%)
IRADIMED CORPORATION Announces Fourth Quarter 2019 Financial Results

IRMD : 22.36 (-0.58%)
IRadimed (IRMD) Reports Next Week: Wall Street Expects Earnings Growth

IRadimed (IRMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

IRMD : 22.36 (-0.58%)
IRADIMED CORPORATION to Hold 2019 Fourth Quarter Financial Results Conference Call on February 6th

IRMD : 22.36 (-0.58%)
IRADIMED CORPORATION Announces Retirement of Brent Johnson and the Appointment of MaryBeth Smith as Vice President of Worldwide Sales

IRADIMED CORPORATION (NASDAQ: IRMD) announced the retirement of Brent Johnson, Executive Vice President of Worldwide Sales and Marketing, effective April 10, 2020 after leading the Company's commercial...

IRMD : 22.36 (-0.58%)
Uptrend Call Working As Iradimed Corp Stock Rises 3.9% (IRMD)

SmarTrend identified an Uptrend for Iradimed Corp (NASDAQ:IRMD) on July 30th, 2019 at $22.77. In approximately 5 months, Iradimed Corp has returned 3.89% as of today's recent price of $23.65.

IRMD : 22.36 (-0.58%)
IRADIMED CORPORATION Completes CE Mark Renewal Process For Its MRI Compatible Patient Vital Signs Monitoring System

IRADIMED CORPORATION (NASDAQ: IRMD), a leader in the development of innovative magnetic resonance imaging ("MRI") medical devices and the only known provider of a non-magnetic intravenous ("IV") infusion...

IRMD : 22.36 (-0.58%)

Van Meerten Stock Picks

5 Great Small Caps
Summary 100% technical buy signals.
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar